![Mechanistic pathways linking elevated lipoprotein(a) [Lp(a)] to residual cardiovascular risk after myocardial infarction.](/_next/image?url=%2Ffig%2FMED-42940145%2F7ff41370.webp&w=1600&q=75&dpl=990665302c1d)
ESC Congress 2026 Abstract
Two inherited risk markers linked to heart disease in relatives
Close relatives had an adjusted hazard ratio of 2.14 for heart disease when an initial family member had high levels of both markers compared with low levels.Close relatives had an adjusted hazard ratio of 2.14 for heart disease when an initial family member had high levels of both markers compared with low levels.
Cohort · 25,062 peopleBiomarkers
Who was studied25,062 first-degree relatives without prior cardiovascular disease, median 13.9 years
What changedRelatives had higher heart disease risk when both markers were high versus low in a family member: adjusted hazard ratio 2.14
The catchWhether screening relatives prevents heart disease was not measured
![The Lipoprotein(a) Lowering Therapeutic Landscape Panel A: Demonstrates the mechanism of action of various intra-hepatic cellular and extra-hepatic non-cellular lipoprotein (a) [Lp(a)] lowering…](/_next/image?url=%2Ffig%2FMED-42873455%2F51415f6d.webp&w=1600&q=75&dpl=990665302c1d)
